The mitochondrion is the biggest producer of reactive oxygen species within the cell, and as a result modafinil could target this organelle to straight inhibit no cost-radical generation and market ATP output, which would are inclined to market raises in creatine-phosphocreatine creation. One very good prospect to get a site of action of modafinil